my 5445 has been researched along with Allodynia in 2 studies
MY 5445: potential platelet aggregation inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bollenbach, M | 1 |
| Lugnier, C | 1 |
| Kremer, M | 1 |
| Salvat, E | 1 |
| Megat, S | 1 |
| Bihel, F | 1 |
| Bourguignon, JJ | 1 |
| Barrot, M | 1 |
| Schmitt, M | 1 |
| Duarte, ID | 1 |
| Ferreira, SH | 1 |
2 other studies available for my 5445 and Allodynia
| Article | Year |
|---|---|
Design and synthesis of 3-aminophthalazine derivatives and structural analogues as PDE5 inhibitors: anti-allodynic effect against neuropathic pain in a mouse model.
Topics: Analgesics; Animals; Hyperalgesia; Male; Mice, Inbred C57BL; Molecular Structure; Neuralgia; Phospho | 2019 |
L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway.
Topics: Analgesics; Animals; Arginine; Carrageenan; Cyclic GMP; Dinoprostone; Hyperalgesia; Male; Methylene | 2000 |